Ads
-
Related paper
- Phosphodiesterase as a Drug Target of Alzheimer’s Disease
- The ACE2 COVID-19 target in Alzheimer’s disease |Biomedgrid
- IN SILICO PUTATIVE DRUG TARGET IDENTIFICATION IN ENTEROBACTER CLOACAE AND HOMOLOGY MODELLING OF A CANDIDATE DRUG TARGET
- THE IMPACT OF EMOTIONS, AMBIGUITY, AND APATHY ON DECISIONMAKING IN INDIVIDUALS WITH ALZHEIMER'S DISEASE: A PROPOSAL TO FACILITATE DIAGNOSIS OF ALZHEIMER'S DISEASE
- Perspectives for Treating Alzheimer’s Disease: A Review on Indigeous Plants for Alzheimer Disease
- Diseases Related to Alzheimer’s Disease and Alzheimer’s Special Care Units (Scu): Mixed Results
- COMPUTER AIDED DRUG DESIGN: A PARADIGM SHIFT TO RATIONAL DRUG DESIGN (A CASE STUDY OF ALZHEIMER’S DRUG INTERPIRDINE FAILURE)
- Cerebrovascular and Blood-Brain Barrier Compromise: A Mechanistic Link between Vascular Disease and Alzheimer’s Disease Subtypes of Neurocognitive Disorders
- Natural Products for the Therapy of Proteinopathies Underlying the Neurodegenerative Conditions: Protein Misfolding and Fibrillization in Alzheimer’s Disease and Parkinson’s Disease| Biomed Grid
- Alzheimer’s Disease